Targeting a largely untapped medical device market in Southeast Asia, Taiwanese and Malaysian academic institutions have tied up with the med-tech industry to promote and develop Taiwanese devices overseas.
HONG KONG – A joint effort by 3SBio Inc. and its new partner Selecta Biosciences Inc. could lead to better treatments for patients with refractory and tophaceous gout. The two companies will work together to combine two products developed independently into one drug that could be distributed globally.
HONG KONG – After decades of trials, blind alleys and false starts, a vaccine for dengue is finally close to market, and patients in Asia may be among the first to benefit from it.
HONG KONG – Just months before the launch of a vaccination campaign, Japan has approved an extended indication for Pfizer Inc.'s pneumococcal conjugate vaccine to cover the elderly.
HONG KONG – After decades of trials, blind alleys and false starts, a vaccine for dengue is finally close to market, and patients in Asia may be among the first to benefit from it.
HONG KONG – Just months before the launch of a vaccination campaign, Japan has approved an extended indication for Pfizer Inc.'s pneumococcal conjugate vaccine to cover the elderly.
HONG KONG – A joint effort by 3SBio Inc. and its new partner Selecta Biosciences Inc. could lead to better treatments for patients with refractory and tophaceous gout. The two companies will work together to combine two products developed independently into one drug that could be distributed globally.
